Nasdaq: BNTC
Benitec Biopharma insiders
The officers, directors and 10% owners of Benitec Biopharma Inc. who hold the most stock, valued at the live BNTC price.
$8.14
BNTC today −$130K (−1.57%)
Market closed. Prices as of Nov 19, 4:04 PM ET
- Ranked insiders
- 3
- Their BNTC stock
- $30.3M
- Market value
- $294M
- Held by ranked insiders
- 10.3%
Insiders by value of BNTC holdings
SEC ownership page| # | Insider | Role | Shares | Value | Of company | Overall rank |
|---|---|---|---|---|---|---|
| 1 | Averill Master Fund, Ltd. | Director | 1,848,156 | $15.0M | 5.12% | Corporate |
| 2 | Suvretta Capital Management, LLC | Director | 1,819,812 | $14.8M | 5.04% | Corporate |
| 3 | J. Kevin Buchi | Director | 52,097 | $424K | 0.14% | 12088th |
Only insiders worth at least $5 million in listed stock are ranked. Holdings come from each insider's latest Form 3, 4 or 5 for Benitec Biopharma; see each profile for the filing.